Pfizer's Lipset assesses use of social media in trials; Data privacy scares continue to rock U.K.;

> Pfizer's ($PFE) Craig Lipset has looked at the risks and benefits of clinical trial participants using social media. Opinion

> A series of data privacy scares has hampered efforts to rebuild trust in the English database of patient records. News

> Worldwide Clinical Trials has picked BioClinica as its CTMS provider. Release

> SAP has released its attempt to accelerate the processing and analysis of genomics data. Item

> The former director of the Virginia Bioinformatics Institute is suing senior administrators over his demotion. News

> Dell ($DELL) and Intel ($INTC) are searching for startups with mobile technologies that improve patient outcomes. Post

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.